AR128054A1 - Sal derivada de triazolona como inhibidor de elastasa de neutrófilos - Google Patents
Sal derivada de triazolona como inhibidor de elastasa de neutrófilosInfo
- Publication number
- AR128054A1 AR128054A1 ARP220103536A ARP220103536A AR128054A1 AR 128054 A1 AR128054 A1 AR 128054A1 AR P220103536 A ARP220103536 A AR P220103536A AR P220103536 A ARP220103536 A AR P220103536A AR 128054 A1 AR128054 A1 AR 128054A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- triazolone
- phenyl
- salt
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/105—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic
- C07C65/11—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic with carboxyl groups on a condensed ring system containing two rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se refiere, en general, a una novedosa sal derivada de triazolona particularmente útil como inhibidor de elastasa de neutrófilos y a su uso como un medicamento. La presente invención también se refiere a composiciones farmacéuticas que comprenden la novedosa sal derivada de triazolona y uno o más vehículos y/o excipientes farmacéuticamente aceptables de esta y a su uso como medicamento. Reivindicación 1: El compuesto hemiembonato de (2-{5-ciano-2-[(R)-6-metoxicarbonil-7-metil-3-oxo-8-(3-trifluorometil-fenil)-2,3,5,8-tetrahidro-[1,2,4]triazolo[4,3-a]pirimidin-5-il]-fenil}-etil)-trimetil-amonio de fórmula (1). Reivindicación 2: Una composición farmacéutica que comprende el compuesto de fórmula (1) de la reivindicación 1 y uno o más vehículos y/o excipientes farmacéuticamente aceptables. Reivindicación 3: Una composición farmacéutica según la reivindicación 2, formulada en forma de un polvo seco. Reivindicación 10: Un procedimiento para la preparación del compuesto de fórmula (1) según la reivindicación 1 al hacer reaccionar el derivado de triazolona de fórmula (2) con una sal de embonato de fórmula (3), dicho proceso comprende los siguientes pasos: 1) disolver en agua una sal hidrosoluble de (2-{5-ciano-2-[(R)-6-metoxicarbonil-7-metil-3-oxo-8-(3-trifluorometil-fenil)-2,3,5,8-tetrahidro-[1,2,4]triazolo[4,3-a]pirimidin-5-il]-fenil}-etil)-trimetil-amonio de fórmula (2) donde X⁻ es un anión orgánico o inorgánico, y 2) añadir una solución de una sal de embonato de fórmula (3) donde Y⁺ es un alcalino o un catión de metal alcalinotérreo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21217142 | 2021-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR128054A1 true AR128054A1 (es) | 2024-03-20 |
Family
ID=79025061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP220103536A AR128054A1 (es) | 2021-12-22 | 2022-12-21 | Sal derivada de triazolona como inhibidor de elastasa de neutrófilos |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250051340A1 (es) |
| EP (1) | EP4452981B1 (es) |
| JP (1) | JP2025501748A (es) |
| KR (1) | KR20240124374A (es) |
| CN (1) | CN118434739A (es) |
| AR (1) | AR128054A1 (es) |
| AU (1) | AU2022418176A1 (es) |
| CA (1) | CA3241548A1 (es) |
| ES (1) | ES3049533T3 (es) |
| MX (1) | MX2024007591A (es) |
| WO (1) | WO2023118258A1 (es) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU650953B2 (en) | 1991-03-21 | 1994-07-07 | Novartis Ag | Inhaler |
| GB201004179D0 (en) | 2010-03-12 | 2010-04-28 | Pulmagen Therapeutics Inflamma | Enzyme inhibitors |
| GB201004178D0 (en) | 2010-03-12 | 2010-04-28 | Pulmagen Therapeutics Inflamma | Enzyme inhibitors |
| ES2700226T3 (es) | 2012-12-18 | 2019-02-14 | Chiesi Farm Spa | Derivados de 3-oxo-2,3,5,8-tetrahidro-[1,2,4]triazolo[4,3-a]pirimidina para el tratamiento de enfermedades respiratorias |
-
2022
- 2022-12-21 EP EP22843266.2A patent/EP4452981B1/en active Active
- 2022-12-21 KR KR1020247024261A patent/KR20240124374A/ko active Pending
- 2022-12-21 WO PCT/EP2022/087169 patent/WO2023118258A1/en not_active Ceased
- 2022-12-21 AR ARP220103536A patent/AR128054A1/es unknown
- 2022-12-21 US US18/720,120 patent/US20250051340A1/en active Pending
- 2022-12-21 MX MX2024007591A patent/MX2024007591A/es unknown
- 2022-12-21 AU AU2022418176A patent/AU2022418176A1/en active Pending
- 2022-12-21 JP JP2024537881A patent/JP2025501748A/ja active Pending
- 2022-12-21 ES ES22843266T patent/ES3049533T3/es active Active
- 2022-12-21 CN CN202280083770.XA patent/CN118434739A/zh active Pending
- 2022-12-21 CA CA3241548A patent/CA3241548A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022418176A1 (en) | 2024-08-01 |
| JP2025501748A (ja) | 2025-01-23 |
| ES3049533T3 (en) | 2025-12-17 |
| CA3241548A1 (en) | 2023-06-29 |
| EP4452981C0 (en) | 2025-08-27 |
| KR20240124374A (ko) | 2024-08-16 |
| MX2024007591A (es) | 2024-07-09 |
| EP4452981B1 (en) | 2025-08-27 |
| US20250051340A1 (en) | 2025-02-13 |
| WO2023118258A1 (en) | 2023-06-29 |
| CN118434739A (zh) | 2024-08-02 |
| EP4452981A1 (en) | 2024-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR112828A1 (es) | Proceso para la preparación de 7-(4,7-diazaespiro[2.5]octan-7-il)-2-(2,8-dimetilimidazo[1,2-b]piridazin-6-il)pirido[1,2-a]pirimidin-4-ona | |
| CN105209463B (zh) | 2‑氨基吡啶并[4,3‑d]嘧啶‑5‑酮衍生物及其作为Wee‑1抑制剂的用途 | |
| CR10095A (es) | Derivados de pirimidina para el tratamiento del crecimiento celular anormal | |
| ECSP10010685A (es) | Sales de 2-fluoro-n-metil-4-[7-(quinolin-6-il-metil)-imidazo[1,2-b][1,2,4]triazin-2-il]benzamida y procesos relacionados con la preparación de las mismas | |
| US20130317021A1 (en) | Heterocyclic pyrimidine carbonic acid derivatives which are useful in the treatment, amelioration or prevention of a viral disease | |
| AR077221A1 (es) | {5-[4-(3,3-dimetil-azetidina-1-carbonil)-fenil]-[1,2,4]triazolo[1,5-a]piridin-2-il} amida del acido ciclopropanocarboxilico inhibidor de quinasas janus(jak), en particular jak1, composiciones farmaceuticas que lo contienen y uso de los mismos para tratar afecciones inflamatorias, autoinmunes y proli | |
| CS228537B2 (en) | Method for the production of methandiole bis-ester with derivates of foaming lanic acid | |
| AR128054A1 (es) | Sal derivada de triazolona como inhibidor de elastasa de neutrófilos | |
| AR117844A1 (es) | Derivados de tiazolopiridina como antagonistas del receptor de adenosina | |
| AR130817A1 (es) | Proceso para la preparación de un agente de contraste de gadolinio | |
| CO2024010726A2 (es) | Compuestos heterocíclicos y métodos de uso | |
| AR128053A1 (es) | Sal derivada de triazolona como inhibidor de elastasa de neutrófilos | |
| AR057291A1 (es) | Proceso para la preparacion de acidos bisfosfonicos geminales y las sales y/o hidratos farmaceuticamente aceptables de los mismos, una composicion farmaceutica que los contiene y el uso de esta en el tratamiento de la osteoporosis | |
| ES2208253T3 (es) | Nuevo derivado de adamantano y composicion desinfectante acuosa que lo contiene. | |
| RU2011108627A (ru) | ИНГИБИТОР PIM1-КИНАЗЫ, 6-[(4-МЕТИЛ-L-1-ПИПЕРАЗИНИЛ)МЕТИЛ]-ИНДОЛО[1',7':1,2,3]ПИРРОЛО[3',4':6,7]АЗЕПИНО[4,5-b]ИНДОЛ-1,3(2Н,10Н)-ДИОН, СПОСОБ ЕГО ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ | |
| EP0000541B1 (en) | 1h-pyrimido-(4,5-c)-1,2-diazepines, methods for their preparation and compositions containing them; their use as intermediates for heterocyclic transformations. | |
| WO2023154905A8 (en) | Antiviral naphthyridinone compounds | |
| OGAWA et al. | Purines. L. Synthesis and antileukemic activity of the antibiotic guanine 7-oxide and its 9-substituted derivatives | |
| US2813866A (en) | 8-r-1, 6, 8-triazabicyclo(4, 3, 0)-3-nonene-7, 9-diones and preparation thereof | |
| deStevens et al. | Investigations in Heterocycles. XI. Tetracyclic and Pentacyclic Indolo [2, 3-a] quinolizines | |
| US3042579A (en) | Bactericidal process using p-hydroxydiphenylamine | |
| US3431262A (en) | Pyrazolo quinoxalines | |
| BRPI0409237A (pt) | composições de suspensão agrìcola-quìmica aquosa | |
| AR074049A1 (es) | Formas cristalinas de sales de (1r*,2r*,4r*)-2-(2-{[3-(4,7-dimetoxi-1h-benzoimidazol-2-il)-propil]-metil-amino}-etil)-5-fenil-biciclo[2.2.2]oct-5-en-2-il ester de ácido isobutirico, composicion farmaceutica que las comprende y su uso en el tratamiento de enfermedades mediadas por bloqueadores del ca | |
| RU2518740C1 (ru) | СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ДИГИДРОХЛОРИД 2-(3,4-МЕТИЛЕНДИОКСИФЕНИЛ)-9-МОРФОЛИНОЭТИЛИМИДАЗО[1,2-a]БЕНЗИМИДАЗОЛА |